allergies

allergies

allergies

EMA gives the green light to the first adrenaline nasal spray for the urgent treatment of allergic reactions

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting marketing authorisation in the European Union for Eurneffy (epinephrine), the first nasally administered medicine for the emergency treatment of allergic reactions. Anaphylaxis is the most severe form of allergic reaction that can occur within minutes of exposure to an allergen and can be life-threatening. Until now, treatment with epinephrine (also known as adrenaline) to reduce the anaphylactic reaction is done by intramuscular injection. 

0

Reactions: two studies describe what may be the cells that sustain allergies over time

Two teams of researchers have separately described a population of memory lymphocytes that may be responsible for the persistence of allergies over time. The work has analysed responses to allergens such as those present in peanuts, dust and birch. According to the authors, whose research is published in Science Translational Medicine, these cells could serve as a target for the treatment of various types of allergies.

0

Reaction: Research links exposure to pets from pregnancy to early childhood with fewer food allergies in babies

Babies who are exposed to dogs and cats during foetal development and early childhood have a lower risk of food allergies up to the age of three, according to a Japanese study published in PLoS ONE. Previous work has focused on the beneficial effect of dogs in this period, while this analysis, based on retrospective data from more than 66,000 children, also includes other pets such as cats and hamsters. According to the study, exposure to dogs is associated with a lower incidence of egg, milk and nut allergies, while contact with cats is linked to a lower incidence of egg, wheat and soy allergies. However, exposure to hamsters is associated with a higher incidence of nut allergy.

0